Search results
Abbvie Inc (ABBV) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 1 day agoThe stock price of Abbvie Inc (NYSE: ABBV) has surged by 1.06 when compared to previous closing price of 164.66, but the company has seen a 2.54% gain in ...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors ...
AbbVie Inc. (NYSE:ABBV) Short Interest Down 10.7% in March
ETF DAILY NEWS· 7 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling ...
Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?
Zacks via Yahoo Finance· 8 hours agoConsumer Discretionary and Healthcare round out the top three. Looking at individual holdings,...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Dakota Wealth Management
ETF DAILY NEWS· 6 days agoDakota Wealth Management trimmed its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 14.1% in the 4th quarter, according to the company in its most ...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks· 2 days agoFree Report) will report first-quarter 2024 results on Apr 26, before market open. In the last reported quarter, the company delivered an earnings surprise of 1.09%. The Zacks Consensus Estimate ...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHRD, AA, FUSN, LABP
WKBN 27 Youngstown· 1 hour agoUnder the terms of the proposed transaction, each common share of Enerplus will be exchanged for 0.10125 shares of Chord common stock and $1.84 per share in cash. Upon completion of the proposed ...
AbbVie (NYSE:ABBV) Shares Up 1.8%
ETF DAILY NEWS· 3 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 1.8% on Thursday . The company traded as high as $167.44 and last traded at $167.14. BMO Capital Markets ...
AbbVie stock gains as Rinvoq succeeds in giant cell arteritis
Seeking Alpha· 5 days agoAbbVie (ABBV) stock gains as the company's JAK inhibitor, upadacitinib, succeeds in a Phase 3 trial...
CVS favors Humira copycats hurting AbbVie’s market (NYSE:CVS)
Seeking Alpha· 6 days agoCVS Health's (CVS)decision to drop coverage for Humira and favor its cheaper biosimilars is hurting...
